NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.74% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.63% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.57% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.55% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.52% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.52% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.50% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.50% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.49% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.49% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.48% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.42% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.39% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.39% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.37% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.34% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.31% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.30% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.22% |